Arena Pharmaceuticals, Inc.
(NASDAQ : ARNA)

( )
ARNA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.80%108.001.1%$623.63m
GILDGilead Sciences, Inc.
2.24%75.880.9%$553.53m
AMGNAmgen Inc.
0.81%176.831.1%$472.09m
REGNRegeneron Pharmaceuticals, Inc.
0.14%381.322.7%$367.77m
BIIBBiogen Inc.
0.69%328.031.2%$319.81m
ALXNAlexion Pharmaceuticals, Inc.
-2.24%111.901.9%$254.48m
NKTRNektar Therapeutics
2.30%55.216.1%$211.68m
VRTXVertex Pharmaceuticals Incorporated
-1.34%141.681.9%$185.36m
ALNYAlnylam Pharmaceuticals, Inc
-2.06%128.2010.0%$179.97m
BLUEBluebird Bio, Inc.
17.91%201.8017.2%$170.21m
ILMNIllumina, Inc.
-1.63%214.113.5%$161.51m
AAgilent Technologies, Inc.
-0.65%66.941.5%$153.46m
INCYIncyte Corporation
0.69%97.252.5%$138.55m
BMRNBioMarin Pharmaceutical Inc.
7.46%88.114.4%$100.29m
JUNOJuno Therapeutics, Inc.
-14.34%50.2413.5%$94.10m

Company Profile

Arena Pharmaceuticals, Inc. is a biopharmaceutical company engages in the discovery, development, and commercialization of novel drugs that target G protien-coupled receptors. It offers a range of drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in San Diego, CA.